122 related articles for article (PubMed ID: 20421333)
1. Cognitive effects of aromatase inhibitor therapy in peripubertal boys.
Hero M; Maury S; Luotoniemi E; Service E; Dunkel L
Eur J Endocrinol; 2010 Jul; 163(1):149-55. PubMed ID: 20421333
[TBL] [Abstract][Full Text] [Related]
2. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature.
Hero M; Mäkitie O; Kröger H; Nousiainen E; Toiviainen-Salo S; Dunkel L
Horm Res; 2009; 71(5):290-7. PubMed ID: 19339794
[TBL] [Abstract][Full Text] [Related]
3. Blockade of oestrogen biosynthesis in peripubertal boys: effects on lipid metabolism, insulin sensitivity, and body composition.
Hero M; Ankarberg-Lindgren C; Taskinen MR; Dunkel L
Eur J Endocrinol; 2006 Sep; 155(3):453-60. PubMed ID: 16914600
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of estrogen biosynthesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial.
Hero M; Norjavaara E; Dunkel L
J Clin Endocrinol Metab; 2005 Dec; 90(12):6396-402. PubMed ID: 16189252
[TBL] [Abstract][Full Text] [Related]
5. Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B.
Hero M; Tommiska J; Vaaralahti K; Laitinen EM; Sipilä I; Puhakka L; Dunkel L; Raivio T
Fertil Steril; 2012 May; 97(5):1242-7. PubMed ID: 22405597
[TBL] [Abstract][Full Text] [Related]
6. Vertebral morphology in aromatase inhibitor-treated males with idiopathic short stature or constitutional delay of puberty.
Hero M; Toiviainen-Salo S; Wickman S; Mäkitie O; Dunkel L
J Bone Miner Res; 2010 Jul; 25(7):1536-43. PubMed ID: 20200972
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled comparison of letrozole to oxandrolone effects upon growth and puberty of children with constitutional delay of puberty and idiopathic short stature.
Salehpour S; Alipour P; Razzaghy-Azar M; Ardeshirpour L; Shamshiri A; Monfared MF; Gharib A
Horm Res Paediatr; 2010; 74(6):428-35. PubMed ID: 20628237
[TBL] [Abstract][Full Text] [Related]
8. Letrozole vs anastrozole for height augmentation in short pubertal males: first year data.
Neely EK; Kumar RB; Payne SL; Ranadive SA; Suchet DI
J Clin Endocrinol Metab; 2014 Nov; 99(11):4086-93. PubMed ID: 25137428
[TBL] [Abstract][Full Text] [Related]
9. A specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial.
Wickman S; Sipilä I; Ankarberg-Lindgren C; Norjavaara E; Dunkel L
Lancet; 2001 Jun; 357(9270):1743-8. PubMed ID: 11403810
[TBL] [Abstract][Full Text] [Related]
10. Novel treatment of delayed male puberty with aromatase inhibitors.
Dunkel L; Wickman S
Horm Res; 2002; 57 Suppl 2():44-52. PubMed ID: 12065927
[TBL] [Abstract][Full Text] [Related]
11. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
Hero M; Wickman S; Dunkel L
Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
[TBL] [Abstract][Full Text] [Related]
12. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor.
Wickman S; Saukkonen T; Dunkel L
Eur J Endocrinol; 2002 Mar; 146(3):339-46. PubMed ID: 11888840
[TBL] [Abstract][Full Text] [Related]
13. Effects of suppression of estrogen action by the p450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys.
Wickman S; Kajantie E; Dunkel L
J Clin Endocrinol Metab; 2003 Aug; 88(8):3785-93. PubMed ID: 12915670
[TBL] [Abstract][Full Text] [Related]
14. Pubertal upregulation of erythropoiesis in boys is determined primarily by androgen.
Hero M; Wickman S; Hanhijärvi R; Siimes MA; Dunkel L
J Pediatr; 2005 Feb; 146(2):245-52. PubMed ID: 15689918
[TBL] [Abstract][Full Text] [Related]
15. Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.
Mauras N; Gonzalez de Pijem L; Hsiang HY; Desrosiers P; Rapaport R; Schwartz ID; Klein KO; Singh RJ; Miyamoto A; Bishop K
J Clin Endocrinol Metab; 2008 Mar; 93(3):823-31. PubMed ID: 18165285
[TBL] [Abstract][Full Text] [Related]
16. Treatment of delayed male puberty: efficacy of aromatase inhibition.
Dunkel L; Wickman S
J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1541-6. PubMed ID: 11837512
[TBL] [Abstract][Full Text] [Related]
17. Novel treatment of short stature with aromatase inhibitors.
Dunkel L; Wickman S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):345-56. PubMed ID: 14623531
[TBL] [Abstract][Full Text] [Related]
18. Update on the role of aromatase inhibitors in growth disorders.
Dunkel L
Horm Res; 2009 Jan; 71 Suppl 1():57-63. PubMed ID: 19153508
[TBL] [Abstract][Full Text] [Related]
19. Circulating makorin ring finger protein 3 levels decline in boys before the clinical onset of puberty.
Varimo T; Dunkel L; Vaaralahti K; Miettinen PJ; Hero M; Raivio T
Eur J Endocrinol; 2016 Jun; 174(6):785-90. PubMed ID: 27025240
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome.
Wikström AM; Bay K; Hero M; Andersson AM; Dunkel L
J Clin Endocrinol Metab; 2006 Nov; 91(11):4705-8. PubMed ID: 16926256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
